KQSSKALQR

KQSSKALQR is a BCR-ABL peptide. KQSSKALQR can induce CD8+T cell responses. KQSSKALQR can be used in vaccine research for chronic myeloid leukaemia (CML) [1].

Product Specifications

CAS Number

[164031-33-8]

UNSPSC

12352209

Target

Others

Related Pathways

Others

Field of Research

Cancer

Smiles

[H]N[C@@H](CCCCN)C(N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)C)=O)=O)=O)=O)=O

Molecular Formula

C43H80N16O14

Molecular Weight

1045.19

References & Citations

[1]Rojas JM, et al. Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study. Leukemia. 2007 Nov;21 (11) :2287-95.